Purchase the ATMP report at www.evernowpublishing.com

Subscribe to MedNous and get ahead in the business of medical innovation. Subscribe now.

The latest MedNous journal. Subscribe to download.

Cold chain technology deal

Country: United Kingdom

GE Healthcare has expanded its capacity for industralising cell therapies with the acquisition of Asymptote Ltd, a UK consultancy with technology for simplifying the freezing of cells intended as therapies, and thawing them before their use in patients.

Read more

FDA says more data needed for baricitinib

Country: United States

The US Food and Drug Administration has turned back an application from Eli Lilly and Company for baricitinib, a candidate treatment for rheumatoid arthritis, saying that more data is needed to determine the most appropriate doses of the drug for use in patients.

Read more

David Meeker to step down from Genzyme

Country: France

Read more

Positive data for HDAC inhibitor - Medivir

Country: Sweden

Read more

Symetis gains access to US market

Country: Switzerland

Read more

Seed funding for Imperial College spin-out

Country: United Kingdom

Read more

Abzena proposes private share placement

Country: United Kingdom

Read more

Verona Pharma plans global share offering

Country: United States

Read more

EMA reaches out to academia

Country: United Kingdom

Read more

Belgium’s Ogeda to be bought by Astellas

Country: Belgium

Read more

Looking for more?

Visit our news section for more articles.

News
Our full Mednous news archive
Appointments
Latest industry appointments
Events
A list of upcoming industry events

About Mednous

MedNous is a print publication and a website for everyone involved in medical research in Europe.

Read more

Free Article

Targeting the tumour microenvironment

subscribers only

Highlights of the March 2017 MedNous issue

The March 2017 MedNous features:

Latest Mednous cover
  • Research Strategy
    Targeting the tumour microenvironment
    Interview with Michel Detheux
  • Oncology Review
    Immunotherapies start to transform cancer care
    By Bruno Pagliara
  • Company Financing
    Breath Therapeutics scoops up €43.5 million
  • Commentary
    The Trump impact on healthcare M&A
    By Tim Sturgeon and Martin Gouldstone
  • Company News
    ALK-Abelló sets sights on US
  • Regenerative Medicine
    TxCell embraces the CAR

The latest MedNous journal. Subscribe to download.